These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7730367)

  • 1. Localization of I2-imidazoline binding sites on monoamine oxidases.
    Tesson F; Limon-Boulez I; Urban P; Puype M; Vandekerckhove J; Coupry I; Pompon D; Parini A
    J Biol Chem; 1995 Apr; 270(17):9856-61. PubMed ID: 7730367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominant expression of monoamine oxidase B isoform in rabbit renal proximal tubule: regulation by I2 imidazoline ligands in intact cells.
    Gargalidis-Moudanos C; Remaury A; Pizzinat N; Parini A
    Mol Pharmacol; 1997 Apr; 51(4):637-43. PubMed ID: 9106629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between I2 imidazoline binding sites and monoamine oxidase B in liver.
    Remaury A; Ordener C; Shih J; Parini A
    Ann N Y Acad Sci; 1999 Jun; 881():32-4. PubMed ID: 10415894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I2-imidazoline binding sites: relationship with different monoamine oxidase domains and identification of histidine residues mediating ligand binding regulation by H+1.
    Limon-Boulez I; Tesson F; Gargalidis-Moudanos C; Parini A
    J Pharmacol Exp Ther; 1996 Feb; 276(2):359-64. PubMed ID: 8632297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney.
    King PR; Suzuki S; Hosseini AR; Iakovidis D; Nero TL; Jackman GP; Louis WJ; Gundlach AL
    J Auton Nerv Syst; 1998 Oct; 72(2-3):118-28. PubMed ID: 9851560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease.
    Gargalidis-Moudanos C; Pizzinat N; Javoy-Agid F; Remaury A; Parini A
    Neurochem Int; 1997 Jan; 30(1):31-6. PubMed ID: 9116585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imidazoline/guanidinium binding domains on monoamine oxidases. Relationship to subtypes of imidazoline-binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase B.
    Raddatz R; Parini A; Lanier SM
    J Biol Chem; 1995 Nov; 270(46):27961-8. PubMed ID: 7499273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes.
    Alemany R; Olmos G; García-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):39-47. PubMed ID: 9228188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of [3H]idazoxan binding proteins in solubilized membranes from rabbit and human liver.
    Remaury A; Missy K; Parini A
    J Auton Nerv Syst; 1998 Oct; 72(2-3):111-7. PubMed ID: 9851559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
    Gargalidis-Moudanos C; Parini A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between imidazoline/guanidinium receptive sites and monoamine oxidase A and B.
    Raddatz R; Lanier SM
    Neurochem Int; 1997 Jan; 30(1):109-17. PubMed ID: 9116581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the pharmacological and molecular heterogeneity of I(2)-imidazoline-binding proteins using monoamine oxidase-deficient mouse models.
    Remaury A; Raddatz R; Ordener C; Savic S; Shih JC; Chen K; Seif I; De Maeyer E; Lanier SM; Parini A
    Mol Pharmacol; 2000 Nov; 58(5):1085-90. PubMed ID: 11040057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of imidazoline-receptor binding sites in cortex and medulla of the bovine adrenal gland. Colocalization with MAO-A and MAO-B.
    King PR; Gundlach AL; Louis WJ
    Ann N Y Acad Sci; 1999 Jun; 881():161-70. PubMed ID: 10415911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imidazoline-binding domains on monoamine oxidase B and subpopulations of enzyme.
    Raddatz R; Savic SL; Bakthavachalam V; Lesnick J; Jasper JR; McGrath CR; Parini A; Lanier SM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1135-45. PubMed ID: 10688633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation between I2-imidazoline receptors and MAO-B activity in platelets of patients with Alzheimer's type dementia.
    Soto J; Ulibarri I; Jauregui JV; Ballesteros J; Meana JJ
    J Psychiatr Res; 1999; 33(3):251-7. PubMed ID: 10367991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology and subcellular distribution of [3H]rilmenidine binding sites in rat brain.
    Hosseini AR; Jackman GP; King PR; Louis WJ; Gundlach AL
    J Auton Nerv Syst; 1998 Oct; 72(2-3):129-36. PubMed ID: 9851561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes.
    Bour S; Iglesias-Osma MC; Marti L; Duro P; Garcia-Barrado MJ; Pastor MF; Prévot D; Visentin V; Valet P; Moratinos J; Carpéné C
    Eur J Pharmacol; 2006 Dec; 552(1-3):20-30. PubMed ID: 17056035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of MAO activity by imidazoline and guanidine derivatives.
    Raasch W; Muhle H; Dominiak P
    Ann N Y Acad Sci; 1999 Jun; 881():313-31. PubMed ID: 10415932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.